Efficacy and Safety of Bimekizumab as Add-On Therapy for Rheumatoid Arthritis in Patients With Inadequate Response to Certolizumab Pegol: A Proof-Of-Concept Study

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2018-214943
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Response To: “A Somatization Comorbidity Phenotype Impacts Response to Therapy in Rheumatoid Arthritis: Post Hoc Results From the Certolizumab Pegol Phase 4 PREDICT Trial”

Arthritis Research & Therapy
2019English

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Efficacy and Safety of Adalimumab in Japanese Patients With Psoriatic Arthritis and Inadequate Response to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): A Prospective, Observational Study

Modern Rheumatology
MedicineRheumatology
2019English

AB0490 Evaluation of Inhibitory Factor of Radiographic Progression by Iguratimod Add-On Therapy in Rheumatoid Arthritis Patients With Inadequate Responses to Disease-Modifying Anti-Rheumatic Drugs

2018English

PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis From a Brazilian Private Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Increasing Levels of Circulating Th17 Cells and Interleukin-17 in Rheumatoid Arthritis Patients With an Inadequate Response to Anti-TNF-Α Therapy

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2011English

Efficacy and Safety of Baricitinib for Active Rheumatoid Arthritis in Patients With an Inadequate Response to Conventional Synthetic or Biological Disease‑modifying Anti‑rheumatic Drugs: A Meta‑analysis of Randomized Controlled Trials

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

Modern Rheumatology
MedicineRheumatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy